REQUEST A DEMO
Total
USD $0.00
Search more companies

Syneos Health D.O.O. (Serbia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Syneos Health D.O.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Syneos Health D.O.O. is an enterprise located in Serbia, with the main office in Belgrade. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was first established on March 06, 2017. It currently has a total number of 767 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 23.58% in 2023. There was a total growth of 3.11% in Syneos Health D.O.O.’s total assets over the same period. In 2023, Syneos Health D.O.O.’s net profit margin increased by 5.3%.

Headquarters
Starine Novaka 23
Belgrade; Belgrade; Postal Code: www.syneoshealth.com

Contact Details: Purchase the Syneos Health D.O.O. report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Syneos Health D.O.O. report to view the information.
Outstanding Shares:
Purchase the Syneos Health D.O.O. report to view the information.
Registered Capital:
Purchase the Syneos Health D.O.O. report to view the information.
Incorporation Date:
March 06, 2017
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Syneos Health D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
23.58%
Total operating revenue
23.59%
Operating profit (EBIT)
185.03%
EBITDA
80.95%
Net Profit (Loss) for the Period
216.24%
Total assets
3.11%
Total equity
54.06%
Operating Profit Margin (ROS)
6.25%
Net Profit Margin
5.3%
Return on Equity (ROE)
17.99%
Debt to Equity Ratio
-63.36%
Quick Ratio
0.35%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?